Market Cap
$9.2B
XPEV
XPENG INC.
$9.25 ▼ -1.80%
Prev close $9.42Market cap$9.2B
ConsensusBuy
12-mo target$18.40 (+99.0%)
▲ Bullish
Analyst conviction 8/10
High Impact Filing (7/10)32 New Institutional Positions9 Institutional Exits Electric Vehicles
Snapshot
The big-picture read on XPEV right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (79%)
Inst. Holders
50 funds
Inst. Value
$1.2B
Inst. Activity
32 buys / 9 sells
Social Sentiment
70° Bullish
SEC Reports
7
Price chart 30d -17.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 29, 2026 short_volume
Sep 1, 2026 SEC Short Volume: XPEV — 55.6% short (3.3M / 5.9M)
Short: 3,281,010 | Exempt: 6,452 | TRF Vol: 5,898,551 | Short Ratio: 55.6% | Off-exchange volume (da
XPeng reported August 2026 vehicle deliveries of 39,107 units, up 4% year-over-year. The filing also notes the debut of
6-K — Impact 4/10
XPENG reported Q2 2026 earnings with total revenues of RMB19.74B (+8.0% YoY) and a net loss of RMB1.34B, which widened s
6-K — Impact 6/10
XPeng announced a ~$900M Series A equity financing for its humanoid robotics subsidiary Dogotix, led by IDG Capital with
6-K — Impact 7/10
Jul 14, 2026 Insider
Yang Donghao acquired via exercise 9,072 shares
Director
Jul 2, 2026 Insider
Wu Jiaming acquired via exercise 43,558 shares
VP Finance & Accounting
Jun 30, 2026 Inst.
MORGAN STANLEY — ADD
9,586,523 shares ($126.9M)
Jun 30, 2026 Inst.
UBS Group AG — ADD
5,580,085 shares ($73.9M)
Analyst ratings buy % +3.9%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
79% rate it Buy or better · 33 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 29, 2026 | JP Morgan | DOWNGRADE | Neutral | 55% |
| Aug 26, 2026 | Barclays | MAINTAIN | Underweight | 54% |
| Aug 25, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Jul 16, 2026 | Barclays | MAINTAIN | Underweight | 54% |
| May 29, 2026 | Macquarie | UPGRADE | Outperform | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 8 | 18 | 5 | 2 | 0 | 79% | |
| Aug 1, 2026 | 8 | 18 | 5 | 2 | 0 | 79% | |
| Jul 1, 2026 | 8 | 17 | 6 | 2 | 0 | 76% | |
| Jun 1, 2026 | 8 | 17 | 6 | 2 | 0 | 76% | |
| May 1, 2026 | 9 | 16 | 7 | 2 | 0 | 74% | |
| Apr 1, 2026 | 9 | 16 | 8 | 1 | 0 | 74% | |
| Mar 1, 2026 | 9 | 18 | 6 | 1 | 0 | 79% | |
| Feb 1, 2026 | 9 | 18 | 6 | 1 | 0 | 79% |
Price targets
Where 25 covering analysts think XPEV trades over the next 12 months.
$18.40 +99.0% upside Strong Buy
Current$9.25 Low$11.51 Median$18.05 High$25.25 25 analysts
$11.51$25.25
Analyst rating Buy· 1.8/5 as of Oct 2, 2026
Social media sentiment mood +20.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
70°
Bullish
BearishNeutralBullish
Recent posts
$XPEV is Unitree’s biggest competitor. Asymmetrical Bet.
▲ 1 · 💬 15· ⚡ 0.5
Xpeng an asymmetrical bet here with Unitree IPO 8,000x oversubscribed
▲ 1 · 💬 3· ⚡ 0.5
Xpeng £1.2m YOLO
▲ 1 · 💬 1· ⚡ 0.5
Unitree 8,000x Over-subscribed, are we going to see a huge "Humanoid stock" pop like Space stocks & SPCX
▲ 1 · 💬 7· ⚡ 0.5
XPEV quietly turning profitable
▲ 1 · 💬 1· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
7 SEC filing reports analyzed · 2 bullish, 1 bearish, 0 mixed, 4 neutral · avg impact 4.3/10.
NEUTRAL6-K4/10
XPeng reported August 2026 vehicle deliveries of 39,107 units, up 4% year-over-year. The filing also
Sep 1, 2026
BEARISH6-K6/10
XPENG reported Q2 2026 earnings with total revenues of RMB19.74B (+8.0% YoY) and a net loss of RMB1.
Aug 25, 2026
BULLISH6-K7/10
XPeng announced a ~$900M Series A equity financing for its humanoid robotics subsidiary Dogotix, led
Aug 24, 2026
NEUTRAL6-K2/10
XPeng filed a Form 6-K to announce a board meeting scheduled for August 24, 2026, to approve and pub
Aug 4, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 29, 2026
short_volume
Short Volume: XPEV — 55.6% short (3.3M / 5.9M)
Short: 3,281,010 | Exempt: 6,452 | TRF Vol: 5,898,551 | Short Ratio: 55.6% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_volume
Short Volume: XPEV — 57.7% short (2.7M / 4.6M)
Short: 2,670,835 | Exempt: 15,721 | TRF Vol: 4,632,565 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
Sep 11, 2026
ftd
FTD: XPEV — 176,644 shares ($1.8M) failed to deliver
Settlement: 20260911, Price: $10.34, FTD Value: $1,826,498.96, XPENG INC.ADS
Sep 10, 2026
short_volume
Short Volume: XPEV — 59.0% short (1.5M / 2.5M)
Short: 1,455,031 | Exempt: 0 | TRF Vol: 2,464,734 | Short Ratio: 59.0% | Off-exchange volume (dark pool + OTC)
Sep 10, 2026
ftd
FTD: XPEV — 436,195 shares ($4.6M) failed to deliver
Settlement: 20260910, Price: $10.57, FTD Value: $4,610,581.15, XPENG INC.ADS
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.90 | $-1.18–$-0.62 | -462.5% | -309.1% | 0↑ 2↓ | $23.8B | 2 |
| Next Q | $0.41 | $0.34–$0.48 | -21.1% | -49.7% | 1↑ 1↓ | $30.8B | 2 |
| Current FY | $-3.46 | $-3.85–$-3.22 | -620.1% | -61.0% | 0↑ 2↓ | $87.1B | 3 |
| Next FY | $1.24 | $-0.48–$2.95 | 135.7% | -59.5% | 0↑ 1↓ | $110.1B | 2 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.900 | — |
| 7d ago | $-0.665 | -0.235 |
| 30d ago | $-0.220 | -0.680 |
| 60d ago | $-0.220 | -0.680 |
| 90d ago | $-0.560 | -0.340 |
Institutional ownership
Which big funds own XPEV (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.2B total value (91,439,379 shares) as of 2026-Q2. Top holders: PRIMECAP, MORGAN, SUSQUEHANNA. Net buying activity: 32 institutions added/increased vs 9 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 12,515,757 | $165.7M | 13.7% | — |
| MORGAN STANLEY | 9,586,523 | $126.9M | 10.5% | ADD +75.9% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 8,439,100 | $111.7M | 9.2% | DOUBLED +101.8% |
| UBS Group AG | 5,580,085 | $73.9M | 6.1% | ADD +26.7% |
| CITADEL ADVISORS LLC | 4,036,718 | $53.4M | 4.4% | DOUBLED +207.2% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 3,937,514 | $52.0M | 4.3% | DOUBLED +1118.5% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3,671,997 | $48.6M | 4.0% | DOUBLED +101.8% |
| CITADEL ADVISORS LLC | 2,521,300 | $33.4M | 2.8% | DOUBLED +207.2% |
| GOLDMAN SACHS GROUP INC | 2,272,316 | $30.1M | 2.5% | TRIM -71.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,271,900 | $30.1M | 2.5% | DOUBLED +101.8% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 5,448,873 | 9,586,523 | +75.9% | $126.9M |
| UBS Group AG | ADD | 4,404,642 | 5,580,085 | +26.7% | $73.9M |
| CITADEL ADVISORS LLC | DOUBLED | 1,313,910 | 4,036,718 | +207.2% | $53.4M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | DOUBLED | 1,819,453 | 3,671,997 | +101.8% | $48.6M |
| GOLDMAN SACHS GROUP INC | TRIM | 7,837,166 | 2,272,316 | -71.0% | $30.1M |
| EXCHANGE TRADED CONCEPTS, LLC | ADD | 1,465,595 | 1,907,468 | +30.1% | $25.3M |
| Legal & General Group Plc | ADD | 981,102 | 1,674,182 | +70.6% | $22.2M |
| BARCLAYS PLC | DOUBLED | 308,887 | 1,463,039 | +373.6% | $19.4M |
| CITIGROUP INC | DOUBLED | 298,050 | 1,350,191 | +353.0% | $17.9M |
| MILLENNIUM MANAGEMENT LLC | DOUBLED | 123,300 | 1,288,529 | +945.0% | $17.1M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
3 insiders, 3 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Yang Donghao | Director | EXERCISE | 9,072 | — | — |
| Jul 2, 2026 | Wu Jiaming | VP Finance & Accounting | EXERCISE | 43,558 | — | — |
| Apr 1, 2026 | Wang Fengying | President | EXERCISE | 600,000 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for XPEV.
Shares short
45,461,636
Settlement Sep 15, 2026
Change vs prior
+0.7%
Semi-monthly cycle
Days to cover
6.4
At avg daily volume
Of shares outstanding
≈4.8%
Estimate — not % of float
All XPEV filing & press-release reports (7)
- 6-K reportSep 1, 2026
- 6-K reportAug 25, 2026
- 6-K reportAug 24, 2026
- 6-K reportAug 4, 2026
- 6-K reportAug 3, 2026
- 6-K reportJul 2, 2026
- 6-K reportJun 26, 2026